ArticleAnalytical and bioanalytical chemistry2026
Cascade-driven dual-signal attenuation antifouling immunosensor for femtogram-level sensing for SCCA.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Nonspecific adsorption compromises the accuracy of electrochemical immunosensors in complex biological samples. Conventional antifouling materials often suffer from poor conductivity, which reduces sensitivity. To address this, a cascade-driven dual-signal attenuation strategy was designed. A hydrophilic conductive composite (GO/AuNPs/PPy/PA/MB, GAPPM) was synthesized via a one‑pot method to fabricate the sensing interface, and capture antibodies were anchored by electrodeposited AuNPs. The immunoprobe was constructed by combining GOx‑encapsulated ZIF‑8 with labeling antibodies linked via in‑situ grown AuNPs. Upon target antigen binding, a sandwich immunocomplex was formed on the electrode surface, and two cascade pathways were activated by glucose: (i) degradation of methylene blue signal molecules was induced, leading to attenuation of the current, and (ii) generation of an insoluble coordination precipitate was promoted, increasing interfacial resistance. Dual‑path cascade signal amplification was thus achieved synergistically. Using squamous cell carcinoma antigen as a model, the immunosensor achieved a detection limit of 29.5 fg mL⁻
Indexed as
Identifiers
42458094What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.